Valuation : PT Itama Ranoraya Tbk

Market Cap 564B 31.85M 27.44M 25.73M 23.49M 44.25M 3.04B 44.39M 305M 119M 1.54B 120M 117M 5.1B P/E 2024
11.3x
P/E 2025 9.99x
Enterprise Value 1,320B 74.53M 64.23M 60.22M 54.97M 104M 7.12B 104M 714M 279M 3.6B 280M 274M 11.92B EV / Sales 2024
1.22x
EV / Sales 2025 1.27x
Free-Float
14.23%
Yield 2024 *
-
Yield 2025 -
1 day+0.54%
1 week+0.54%
Current month-0.53%
3 months-0.53%
6 months-9.66%
Current year-11.79%
1 week 366
Extreme 366
380
1 month 364
Extreme 364
384
Current year 322
Extreme 322
615
1 year 322
Extreme 322
615
3 years 322
Extreme 322
1,045
5 years 322
Extreme 322
2,240
10 years 322
Extreme 322
4,390
Manager TitleAgeSince
Chief Executive Officer 62 12/11/2020
Director of Finance/CFO 53 29/04/2024
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 71 12/11/2020
Director/Board Member 62 31/12/2021
Director/Board Member - 31/12/2024
Change 5-day change 1-year change 3-year change Capi.($)
+0.54%+0.54%-13.82%-20.09% 31.85M
+0.79%-3.58%-15.22%+8.28% 195B
+1.40%-2.27%-1.70%+11.15% 117B
+0.25%+1.25%+10.43%+78.93% 61.45B
+0.74%-1.29%-1.79%-32.67% 51.62B
-0.25%-1.97%+26.78%+53.20% 51.03B
+1.71%-1.65%+20.55%-9.70% 34.27B
+1.82%+2.98% - - 30.95B
-2.49%-4.42%+36.66%-18.17% 23.75B
-0.82%-1.17%-4.67%+17.85% 23.41B
Average +0.37%-0.93%+6.36%+9.86% 58.79B
Weighted average by Cap. +0.67%-1.86%+0.39%+15.16%

Financials

2024 2025
Net sales 977B 55.21M 47.57M 44.6M 40.72M 76.7M 5.28B 76.95M 529M 206M 2.66B 207M 203M 8.83B 1,100B 62.14M 53.54M 50.2M 45.83M 86.33M 5.94B 86.61M 596M 232M 3B 233M 228M 9.94B
Net income 53.26B 3.01M 2.59M 2.43M 2.22M 4.18M 288M 4.19M 28.83M 11.25M 145M 11.29M 11.05M 481M 65.53B 3.7M 3.19M 2.99M 2.73M 5.14M 354M 5.16M 35.48M 13.84M 179M 13.9M 13.59M 592M
Net Debt 593B 33.46M 28.84M 27.04M 24.68M 46.49M 3.2B 46.64M 321M 125M 1.61B 126M 123M 5.35B 756B 42.69M 36.78M 34.49M 31.48M 59.31M 4.08B 59.49M 409M 160M 2.06B 160M 157M 6.83B
Logo PT Itama Ranoraya Tbk
PT Itama Ranoraya Tbk is an Indonesia-based healthcare company engaged in offering healthcare solutions. The Company's main activity is to operate in the field of wholesale trading of laboratory equipment, pharmaceutical equipment, and medical devices for humans. Its segments include In Vitro Diagnostic (IVD) Product, Sterile Non-Electromedical Medical Equipment, Electromedical Medical Equipment, and Others. Its business segment focuses on IVD, medical imaging, surgical, cardiovascular, hospital supplies, critical care, maternal and neonatal care, pharmaceuticals, and among others. In addition to carrying out its main business activities, the Company also leases office space to PT Neumedik Jaya.
Employees
232
Date Price Change Volume
28/08/26 IDR 374.00 +0.54% 649,700
27/08/26 IDR 372.00 +1.09% 451,100
26/08/26 IDR 368.00 -1.08% 257,100
24/08/26 IDR 372.00 0.00% 564,500
21/08/26 IDR 372.00 -0.53% 568,600
  1. Stock Market
  2. Stocks
  3. IRRA Stock